FIELD: biotechnologies.
SUBSTANCE: invention relates to the biotechnology. Described are antisense oligonucleotides consisting of 10–28 nucleotides, and at least two of 10–28 nucleotides represent LNA, and the antisense oligonucleotide is complementary to a region of the gene coding TGF-RII, or a region of mRNA encoding TGF-RII. What is described is a pharmaceutical composition containing such antisense oligonucleotides.
EFFECT: said nucleotides are used for preventing and treating neurological, neurodegenerative, fibrotic and hyperproliferative diseases.
14 cl, 32 dwg, 85 tbl, 640 ex
| Title |
Year |
Author |
Number |
| ANTISENSE OLIGONUCLEOTIDES TO ALPHA-SYNUCLEIN AND APPLICATIONS THEREOF |
2019 |
- Khagedorn, Peter
- Olson, Richard E.
- Kakas, Andzhela M.
- Ensen, Mariann Lerbek
- Braun, Dzheffri M.
- Meredit, Dzhr., Dzhere E.
- Pendri, Annapurna
- Makdonald, Ajvar M.
- Dzhill, Martin
|
RU2773197C2 |
| AMPHIREGULIN GENE-SPECIFIC DOUBLE-STRANDED OLIGONUCLEOTIDES AND COMPOSITIONS CONTAINING THEM FOR THE PREVENTION AND TREATMENT OF FIBROSIS-RELATED DISEASES AND RESPIRATORY DISEASES |
2019 |
- Kim, Tae-Rim
- Yoon, Pyoung Oh
- Ko, Youngho
- Bae, Seon Joo
- Park, Han-Oh
- Son, Seung Seob
- Jun-Hong, Park
- Yun, Sung Il
|
RU2795179C2 |
| OLIGONUCLEOTIDES FOR LOWERING PD-L1 EXPRESSION |
2017 |
- Pedersen Lyukke
- Yavanbakkht Khassan
- Yakerott Malene
- Ottosen Seren
- Luangsej Sufalon
|
RU2747822C2 |
| DOUBLE-CHAINED OLIGONUCLEOTIDE SPECIFIC TO CTGF GENE AND COMPOSITION CONTAINING IT FOR PREVENTION AND TREATMENT OF FIBROUS DISEASES AND DISEASES ASSOCIATED WITH RESPIRATORY SYSTEM |
2020 |
- Park, Han-Oh
- Kim, Tae-Rim
- Ko, Young-Ho
- Yun, Sung Il
- Park, Jun Hong
|
RU2807108C1 |
| TREATMENT OF TUMORS OF DISEASES RELATED TO THE GENOM-SUPPRESSOR BY THERAPY OF NATURAL TRANSCRIPT INHIBITION IN ANTI-SIGNIFICANT ORIENTATION REGARDING THIS GENE |
2009 |
- Kollard Dzhozef
- Khorkova Sherman Olga
|
RU2746478C2 |
| COMPOSITIONS AND METHODS FOR REDUCING TAU EXPRESSION |
2016 |
- Polydoro Ofengeim, Manuela
- Weiler, Jan
|
RU2747734C2 |
| COMPOSITIONS AND METHODS FOR REDUCING TAU EXPRESSION |
2016 |
- Polydoro Ofengeim, Manuela
- Weiler, Jan
|
RU2777570C2 |
| NUCLEIC ACID MOLECULES FOR REDUCING THE LEVEL OF PAPD5 OR PAPD7 MRNA FOR TREATING INFECTIOUS HEPATITIS B |
2017 |
- Yavanbakkht, Khassan
- Myuller, Khenrik
- Ottosen, Seren
- Pedersen, Lyukke
|
RU2768699C2 |
| COMPOSITION FOR PREVENTION OR TREATMENT OF DISEASE ASSOCIATED WITH OBESITY, CONTAINING AMPHIREGULIN-SPECIFIC DOUBLE-CHAIN OLIGONUCLEOTIDE STRUCTURE |
2021 |
- Park, Jun Hong
- Park, Han-Oh
- Yun, Sung Il
- Kim, Tae Rim
- Hwang, Soo Hyun
- Song, Kang
- Jung, Sang Hyuk
- Kim, Jangseon
- Lee, Mi Sun
- Choi, Soonja
- Son, Seung-Seob
|
RU2810514C1 |
| METHODS FOR TREATMENT OF HEPATITIS B INFECTION |
2018 |
- Koser, Martin
- Abrams, Marc
|
RU2780021C2 |
